View Item 

Show simple item record

Effects of morphine, nalorphine and naloxone on neocortical release of acetylcholine in the rat
dc.contributor.authorMatthews, John D.en_US
dc.contributor.authorLabrecque, Gastonen_US
dc.contributor.authorDomino, Edward F.en_US
dc.date.accessioned2006-09-11T17:43:06Z
dc.date.available2006-09-11T17:43:06Z
dc.date.issued1973-06en_US
dc.identifier.citationMatthews, John D.; Labrecque, Gaston; Domino, Edward F.; (1973). "Effects of morphine, nalorphine and naloxone on neocortical release of acetylcholine in the rat." Psychopharmacologia 29(2): 113-120. <http://hdl.handle.net/2027.42/46384>en_US
dc.identifier.issn1432-2072en_US
dc.identifier.issn0033-3158en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/46384
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=4709835&dopt=citationen_US
dc.description.abstractThe effects of morphine (10 mg/kg), nalorphine (1 and 10 mg/kg), and naloxone (1 mg/kg) were studied on the neocortical release of acetylcholine (ACh) in midpontine pretrigeminal transected rats. Morphine and, to a lesser extent, nalorphine decreased ACh release. Naloxone was ineffective alone but antagonized the action of morphine.en_US
dc.format.extent420776 bytes
dc.format.extent3115 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherSpringer-Verlagen_US
dc.subject.otherMorphineen_US
dc.subject.otherBiomedicineen_US
dc.subject.otherNaloxoneen_US
dc.subject.otherPharmacology/Toxicologyen_US
dc.subject.otherPsychiatryen_US
dc.subject.otherAcetylcholineen_US
dc.subject.otherNalorphineen_US
dc.subject.otherNeocortexen_US
dc.titleEffects of morphine, nalorphine and naloxone on neocortical release of acetylcholine in the raten_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelPsychiatryen_US
dc.subject.hlbsecondlevelNeurosciencesen_US
dc.subject.hlbsecondlevelChemistryen_US
dc.subject.hlbsecondlevelBiological Chemistryen_US
dc.subject.hlbtoplevelScienceen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumMichigan Neuropsychopharmacology Research Program, Department of Pharmacology, University of Michigan, 48104, Ann Arbor, Michiganen_US
dc.contributor.affiliationumMichigan Neuropsychopharmacology Research Program, Department of Pharmacology, University of Michigan, 48104, Ann Arbor, Michigan; Loma Linda Medical School, Loma Linda, Californiaen_US
dc.contributor.affiliationumMichigan Neuropsychopharmacology Research Program, Department of Pharmacology, University of Michigan, 48104, Ann Arbor, Michigan; Department of Pharmacology, Laval University, Quebec City, Canadaen_US
dc.contributor.affiliationumcampusAnn Arboren_US
dc.identifier.pmid4709835en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/46384/1/213_2004_Article_BF00422643.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1007/BF00422643en_US
dc.identifier.sourcePsychopharmacologiaen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
213_2004_Article_BF00422643.pdf
Size:
410.9KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe its collections in a way that respects the people and communities who create, use, and are represented in them. We encourage you to Contact Us anonymously if you encounter harmful or problematic language in catalog records or finding aids. More information about our policies and practices is available at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.